SEC Comment Letter 0000000000-23-012893 to STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194) (LAB)

STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194)
Date: Nov. 27, 2023 · CIK: 0001162194 · Accession: 0000000000-23-012893

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275533

Date

November 27, 2023

Author

Not clearly detected

Form

UPLOAD

Company

STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194)

Letter

United States securities and exchange commission logo November 27, 2023 Michael Egholm, Ph.D. President and Chief Executive Officer STANDARD BIOTOOLS INC. 2 Tower Place, Suite 2000 South San Francisco, CA 94080 Re:STANDARD BIOTOOLS INC. Registration Statement on Form S-4 Filed November 13, 2023 File No. 333-275533 Dear Michael Egholm: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Matthew Gardella

Show Raw Text

United States securities and exchange commission logo
November 27, 2023
Michael Egholm, Ph.D.
President and Chief Executive Officer
STANDARD BIOTOOLS INC.
2 Tower Place, Suite 2000
South San Francisco, CA 94080
Re:STANDARD BIOTOOLS INC.
Registration Statement on Form S-4
Filed November 13, 2023
File No. 333-275533
Dear Michael Egholm:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Matthew Gardella

SecProbe.io